Home >
International sites
Click on the name of an international website to read its description.
International
International Federation of Psoriasis Associations / IFPA
The International Federation of Psoriasis Associations (IFPA) is a non profit organization made up of psoriasis associations from around the world.
IFPA unites psoriasis associations so that their global campaign for improved medical care, greater public understanding and increased research will improve the lives of people who live with psoriasis and psoriatic arthritis and explore the challenges psoriasis presents to the international psoriasis community.
International Society of Dermatology
The International Society of Dermatology was founded by Dr. Aldo Castellani and Dr. Frederick Reiss in 1959. The organization was initially the "International Society of Tropical Dermatology". The Society had a particular interest in global dermatology and tropical skin diseases but also had a broad interest in all aspects of dermatology as basic sciences, venereology and public health, and in teaching dermatology in developing countries.
World Psoriasis Day 29 October
World Psoriasis Day 29 October. IFPA, the International Federation of Psoriasis Associations and a global consortium of patient associations from all over the world have come together and this day has officially been declared World Psoriasis Day.
Its purpose? To act as a focus for people - awareness of psoriasis and to give these people the attention and consideration they deserve.
SOLAPSO - Sociedad Latinoamericana de Psoriasis
SOLAPSO (Sociedad Latinoamericana de Psoriasis) is a new organization which invites professionals in health from Latin America, who have an special interest in Psoriasis.
Our main aims are the following:
- Encourage Psoriasis research development and medical advance in Latin America.
- Foster the academic education of medical doctors specialized in Psoriasis, by means of human resources training and research.
- Encourage Psoriasis media information through health professionals entertainment programs in Latin-American countries.
- Foster information and vocational training exchange with other international organizations.
- Generate the necessary resources to promote Psoriasis teaching, research and training of young doctors specializing in psoriasis.
- Support scientific psoriasis publications.
- Encourage interdisciplinary work.
LATINAPSO - Red Latinoamericana de Psoriasis
LATINAPSO - the Latina American Psoriasis Network gathers several psoriasis patients associations that fight to improve the quality of life of those who suffer from this disease.
Motivated against the global ignorance of psoriasis in Latin America, the patient associations of Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, Panama, Puerto Rico and Venezuela have decided to come together in order to stregthen their fight for psoriasis patients’ rights.
GRAPPA - Group for Research and Assessment of Psoriasis and Psoriatic Arthritis
GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) is organized exclusively for non-profit, educational, and scientific purposes, specifically to facilitate sharing of information related to psoriasis and psoriatic arthritis, networking among different medical disciplines that see psoriasis and psoriatic arthritis patients and to enhance research, diagnosis and treatment of psoriasis and psoriatic arthritis. More than 400 rheumatologists, dermatologists and related professionals comprise the worldwide membership of GRAPPA.
International Psoriasis Council
The International Psoriasis Council (IPC) is a dermatology led, global nonprofit organization dedicated to innovation across the full spectrum of psoriasis through research, education and treatment. IPC identifies research priorities, brings international experts together and facilitates discussion to provide the best evidence based education for dermatologists and treatment for patients.
International League of Dermatological Societies
Officially founded in 1935, the International League of Dermatological Societies (ILDS) has been promoting skin health around the world for over 80 years. Its forerunner began in 1889 as the first of many World Congresses of Dermatology. Today, the ILDS represents dermatology at the highest level with over 180 Member Societies from more than 80 countries, we represent over 200,000 dermatologists. ILDS works closely with partners around the world including the World Health Organization (WHO), with whom we are in official relations, in order to improve skin health for all people around the world.
Europe
European Federation of Psoriasis Associations / EUROPSO
Europso was founded in November 1988 and is a federation of psoriasis patients’ associations based in the geographic region of Europe. As an umbrella organisation operating within Europe, and as a Member of IfpA we have close ties to the worldwide psoriasis movements – the International Federation of Psoriasis Associations (IFPA), the United States-based National Psoriasis Foundation (NPF) and to the Nordic Psoriasis alliance (NORDPSO).
Psonet - European registry of psoriasis
Psonet is a network of independent European registries of patients suffering from psoriasis or psoriatic arthritis and being treated by systemic agents. The final aim is to improve knowledge concerning prognostic factors and clinical outcome, offering psoriatic patients the best possible treatment.
EADV | European Academy of Dermatology and Venereology
The European Academy of Dermatology and Venereology was founded as a non-profit association (or association sans but lucratif) on the 3rd of October 1987 in Luxembourg. The vision of the EADV is to be the premier European Dermato-Venereology Society with the important aims of leading to improved quality patient care, continuing medical education for all Dermato-Venereologists within Europe, and advocacy on behalf of the speciality and patients.
SPIN Presentation
Recent news
- 2019/10/29 Focus on...
- 2019/08/12 Focus on...
Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis
- 2019/06/03 Focus on...
- 2019/05/21 Focus on...
Prof Nelida Aurora Raimondo
News from the web office
- 2016/10/29
- 2016/05/26
- 2016/02/20
Events
- 2019/04/18 Focus on...
- 2018/02/21
News from medical groups
- 2018/04/18
- 2017/06/21
News from patients associations
- 2017/02/08
- 2016/05/26
Recent publications on Psoriasis and Atopic Dermatitis
on Psoriasis
Discovery of benzo[f]pyrido[4,3-b][1,4]oxazepin-10-one derivatives as orally available bromodomain and extra-terminal domain (BET) inhibitors with efficacy in an in vivo psoriatic animal model.
Bioorg Med Chem.
2021 Mar 15, 34:116015.
Bromodomain and extra-terminal domain (BET) protein plays an important role in epigenetic regulation, and the regulation of disruption contributes to the pathogenesis of cancer and inflammatory disease. With the goal of discovering novel BET inhibitors, especially BRD4 inhibitors, we designed and synthesized several compounds starting from our previously reported pyrido-benzodiazepinone derivative 4 to enhance BRD4 inhibitory activity while avoiding hERG inhibition. Molecular docking (...)
see on pubmed
Clinical trait-connected network analysis reveals transcriptional markers of active psoriasis treatment with Liangxue-Jiedu decoction.
J Ethnopharmacol.
2021 Mar 25, 268:113551.
Psoriasis is a complex recurrent inflammatory skin disease with different pathological changes in different stages. Psoriasis in its active stage, which is comparable to the blood-heat type in traditional Chinese medicine (TCM), has been treated by Liangxue Jiedu Decoction (LJD) in TCM for decades, with proven efficacy. According to TCM theories, LJD has the function of removing heat and pathogenic factors from the (...)
see on pubmed
Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways.
Bioengineered.
2021 Dec , 12, (1):183-195.
Psoriasis is a chronic inflammatory skin disease that affects approximately 2% of worldwide population, and causing long-term troubles to the patients. Therefore, it is urgent to develop safe and effective therapeutic drugs. Catalpol is a natural iridoid glucoside, that has several remarkable pharmacological effects, however, whether catalpol can alleviated psoriasis has not been explored. The goal of the present work is to study the role of catalpol in psoriasis in vivo and in vitro. (...)
see on pubmed
on Atopic Dermatitis
Psychiatric and Nonpsychiatric Comorbidities Among Children With ADHD: An Exploratory Analysis of Nationwide Claims Data in Germany.
J Atten Disord.
2021 Apr , 25, (6):874-884.
This study examined the full spectrum of comorbid disorders in all statutory-health-insured children aged 5 to 14 years with ADHD in 2017 by using nationwide claims data in Germany. Children with ADHD ( = 258,662) were compared for the presence of 864 comorbid diseases with a control group matched by gender, age, and region of residence ( = 2,327,958). Among others, metabolic disorders (odds ratio [OR] = 9.18; 95% confidence interval [CI] = [8.43, 9.99]), viral pneumonia (OR = 4.95; 95% (...)
see on pubmed
Qingxue jiedu formulation ameliorated DNFB-induced atopic dermatitis by inhibiting STAT3/MAPK/NF-κB signaling pathways.
J Ethnopharmacol.
2021 Apr 24, 270:113773.
Qingxue jiedu Formulation (QF) is composed of two classic prescriptions which have been clinically used for more than 5 centuries and appropriately modified through basic theory of traditional Chinese medicine for treating various skin inflammation such as atopic dermatitis (AD), acute dermatitis and rash. Although QF possesses a prominent clinical therapeutic effect, seldom pharmacological studies on its anti-AD activity are (...)
see on pubmed
Methicillin-resistant from infected skin lesions present several virulence genes and are associated with the CC30 in Brazilian children with atopic dermatitis.
Virulence.
2021 Dec , 12, (1):260-269.
Atopic dermatitis (AD) is a chronic inflammatory skin disease and colonization by may affect up to 100% of these patients. Virulent and resistant isolates can worsen AD patient clinical condition and jeopardize the treatment. We aimed to detect virulence genes and to evaluate the biofilm production of isolates from infected skin lesions of children with AD. Methicillin resistance was detected by phenotypic and molecular tests and the virulence genes were detected by PCR. Biofilm formation (...)
see on pubmed